Skip to main content
. 2023 Feb 9;15(4):878. doi: 10.3390/nu15040878

Table 1.

Summary of findings related to nuts and diabetes related prevention and management.

Variables Finding 1 Level of Evidence 2 Reference
Epidemiological Evidence
Fasting blood glucose + [11]
Plasma insulin +
HOMA-IR + [11,12]
HOMA-B + [11]
HbA1c +
OGTT +
Diabetes incidence ↓/↔ + [13,14]
Diabetes prevalence ↓/↔ + [13,15,16,17]
CVD incidence in participants with T2D + [18]
Diabetes mortality ++ [19]
Clinical Trial Evidence
Acute Trial Evidence
In participants free of T2D:
Postprandial glycemia ++ [20,21,22,23,24,25,26]
Postprandial insulinemia ↓/↔ + [21,27,28]
In participants with T2D:
Postprandial glycemia + [21,23,29,30]
Postprandial insulinemia ↓/↔ + [21,29]
Glucose metabolic clearance rate + [29]
Longer-term Trial Evidence
In participants free of T2D at baseline:
Diabetes incidence ↓/↔ + [31,32,33]
In participants with T2D at baseline:
Fasting glucose + [30,34,35,36,37,38,39]
Fasting insulin +
HbA1c +
HOMA-IR +
In participants with/without T2D at baseline:
Fasting glucose + [40]
Fasting insulin +
HbA1c +
HOMA-IR +

Abbreviations: CVD, cardiovascular disease; HbA1c, glycated hemoglobin; HOMA, homoeostasis model assessment; IR, insulin resistance; OGTT, oral glucose tolerance test; T2D, type 2 diabetes mellitus. 1 Findings are based on the authors’ review, and assessment of the noted literature, and hence could present some subjectivity. In general: ↓, majority of evidence indicated a decrease; ↑, majority of evidence indicated an increase; ↔, majority of evidence indicated no change observed; ↓/↔, majority of evidence was split between showing a decrease or no effect on the outcome. Where “majority of evidence” refers to the entirety of the evidence, if a relevant systematic review and meta-analysis was conducted these findings were used as the basis of this determination. 2 Level of Evidence is based on the authors’ review and assessment and, hence, could present with some subjectivity. In general: +, limited and/or inconsistent evidence from few studies in the denoted type of study design; ++, consistent evidence in several studies in the denoted type of study design.